EQUITY RESEARCH MEMO

OsteoCentric Technologies

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)50/100

OsteoCentric Technologies, founded in 2014 and headquartered in Memphis, Tennessee, is a private medical device company focused on advancing orthopedic and dental implant solutions through its proprietary Unifi Mechanical Integration (UnifiMI) technology. UnifiMI provides instant, multi-axial stability and load sharing by mechanically integrating with bone, addressing challenges in normal and compromised bone environments. The company collaborates closely with design surgeons to develop and refine its implants, targeting improved patient outcomes and reduced complication rates. While still early-stage, OsteoCentric's technology has the potential to differentiate in the competitive orthopedic and dental implant markets. The company's success hinges on regulatory clearances, clinical validation, and strategic partnerships to drive adoption.

Upcoming Catalysts (preview)

  • Q4 2026FDA 510(k) clearance for flagship orthopedic implant70% success
  • Q2 2027Strategic partnership with major orthopedic company40% success
  • Q1 2027First-in-human clinical study results60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)